FIELD: medicine, allergology. SUBSTANCE: before the onset of therapeutic impact patient's blood is tested in vitro. Lymphocyte suspension is divided into two parts, a solvent is introduced into a control sample, ketotiphene is introduced into experimental sample at 100 mg/ml final concentration. Both samples are incubated in a thermostat for 2 hours followed by calculating nonadhesive lymphocytes in every sample. At 30% decrease of their amount against a control therapeutic sensitivity to ketotiphene is determined. EFFECT: higher efficiency in revealing in vitro the patients with specific morpho-functional properties of lymphocytes. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING ACTIVITY OF COMPLEMENT, AND GEL INTENDED FOR USE IN THIS METHOD | 1996 |
|
RU2124209C1 |
METHOD DETERMINING SPONTANEOUS CELL CYTOTOXICITY | 2001 |
|
RU2208786C1 |
METHOD FOR DIAGNOSING DELAYED ALLERGIC REACTION | 1991 |
|
RU2008687C1 |
METHOD FOR DETERMINATION OF FUNCTIONAL ACTIVITY OF PHAGOCYTES (FAF) | 2005 |
|
RU2289816C1 |
METHOD FOR PREPARING LABORATORY RAT PERITONEAL MAST CELLS | 2002 |
|
RU2234092C1 |
METHOD FOR TREATING LARYNX PAPILLOMATOSIS IN CHILDREN | 1995 |
|
RU2111755C1 |
METHOD FOR DETECTING PHAGOCYTIC ACTIVITY OF NEUTROPHILS IN PERIPHERAL BLOOD OF ALIVE ORGANISMS | 2003 |
|
RU2242763C1 |
METHOD OF SANITATION OF WOMEN WITH MASSIVE MICROBE DISSEMINATION OF BREAST MILK | 1996 |
|
RU2134583C1 |
METHOD FOR TREATMENT OF ACCOMMODATION CRAMP | 1992 |
|
RU2070024C1 |
AGENT FOR TICOSIS HYPERKINESIS TREATMENT | 1995 |
|
RU2099079C1 |
Authors
Dates
1997-10-10—Published
1994-09-30—Filed